The ISPOR Central and Eastern Europe Consortium is comprised of professionals interested in promoting health economics and outcomes research (HEOR) excellence to improve healthcare decision making in the region and globally. The Central and Eastern Europe Consortium provides a platform for information sharing and institutional collaboration on HEOR and health policy, facilitating professional networking opportunities through scientific activities and global ISPOR initiatives.
- ISPOR EMEA Global Groups – CEE Consortium, Arabic Network, Africa Network and Regional Chapters are contributing with a number of activities to ISPOR Europe 2018: The Executive Committees of the ISPOR EMEA Global Groups will meet in Barcelona (prior RSVP was requested) to discuss their groups’ Annual Agendas for 2019. Several ISPOR Chapters from the region hold meetings to update on the current HEOR trends and collaborative activities in their regions. The EMEA global groups are delivering Forum presentations on Monday and Tuesday and the ISPOR CEE Consortium Reception on Monday evening will offer a great opportunity to connect with peers and experts from the region. Go to the ISPOR Europe 2018 site
Value in Health Regional Issues
Value in Health Regional Issues is a MEDLINE®-indexed, scientific, peer-reviewed journal to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in healthcare decisions in Central and Eastern Europe, Western Asia, and Africa. Manuscript submission is open year-round.
News Across Central and Eastern Europe, Western Asia, and Africa
News Across Central and Eastern Europe, Western Asia, and Africa is the the Central and Eastern Europe Consortium newsletter.
Therapeutic and Diagnostic Device Outcomes Research
Therapeutic and Diagnostic Device Outcomes Research is now available in Polish and Serbian!
ISPOR's Health Technology Assessment Central is a comprehensive repository of resources and tools to support health technology assessment (HTA). HTA Central helps bridge the gap between health economics and outcomes research and other disciplines that inform HTA and healthcare decisions.
The ISPOR Global Healthcare Systems Road Map provides information on country/region-specific decision-making processes for regulatory (market access) approval, reimbursement and economic evaluations of pharmaceuticals and medical devices and diagnostics.
ISPOR recognizes members and thought leaders in the field of health economics and outcomes research through a wide variety of scientific achievement and leadership awards, research presentation awards, and conference travel grants.